Sittner & Nelson’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $792K | Buy |
17,112
+365
| +2% | +$16.9K | 0.32% | 59 |
|
|
2025
Q1 | $1.02M | Buy |
16,747
+19
| +0.1% | +$1.16K | 0.44% | 41 |
|
|
2024
Q4 | $946K | Buy |
16,728
+13
| +0.1% | +$735 | 0.41% | 46 |
|
|
2024
Q3 | $865K | Buy |
16,715
+4,726
| +39% | +$245K | 0.39% | 47 |
|
|
2024
Q2 | $498K | Buy |
11,989
+617
| +5% | +$25.6K | 0.25% | 61 |
|
|
2024
Q1 | $617K | Buy |
11,372
+1,005
| +10% | +$54.5K | 0.31% | 56 |
|
|
2023
Q4 | $532K | Buy |
10,367
+837
| +9% | +$42.9K | 0.28% | 59 |
|
|
2023
Q3 | $553K | Sell |
9,530
-55
| -0.6% | -$3.19K | 0.32% | 56 |
|
|
2023
Q2 | $613K | Buy |
9,585
+20
| +0.2% | +$1.28K | 0.34% | 55 |
|
|
2023
Q1 | $663K | Sell |
9,565
-21
| -0.2% | -$1.46K | 0.38% | 49 |
|
|
2022
Q4 | $690K | Buy |
9,586
+3
| +0% | +$216 | 0.42% | 50 |
|
|
2022
Q3 | $681K | Buy |
9,583
+1,552
| +19% | +$110K | 0.46% | 43 |
|
|
2022
Q2 | $618K | Buy |
8,031
+1,164
| +17% | +$89.6K | 0.4% | 48 |
|
|
2022
Q1 | $502K | Buy |
6,867
+3
| +0% | +$219 | 0.29% | 56 |
|
|
2021
Q4 | $428K | Buy |
6,864
+204
| +3% | +$12.7K | 0.25% | 68 |
|
|
2021
Q3 | $394K | Buy |
6,660
+3
| +0% | +$177 | 0.25% | 69 |
|
|
2021
Q2 | $445K | Buy |
6,657
+3
| +0% | +$201 | 0.31% | 57 |
|
|
2021
Q1 | $420K | Buy |
6,654
+59
| +0.9% | +$3.72K | 0.31% | 59 |
|
|
2020
Q4 | $409K | Buy |
+6,595
| New | +$409K | 0.37% | 55 |
|